Roger von Moos

Kantonsspital Graubünden — Switzerland

Medicine · Health Sciences

48h-index9.5kcitations397works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and treatments(83), Cancer Treatment and Pharmacology(81), Colorectal Cancer Treatments and Studies(56), Cancer Diagnosis and Treatment(45), Radiopharmaceutical Chemistry and Applications(35)

Publications393 total

Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study
The Lancet Regional Health - Europe·2025Open Access
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)
ESMO Open·2025Open Access
P3.18.82 Towards Harmonization of Clinical Care and Promoting Research for Thymic Epithelial Tumors: THETIS (THymic Cancers NETwork in Switzerland)
Journal of Thoracic Oncology·2025
The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Swiss Medical Weekly·2025· 1 citedOpen Access
Abstract PS5-06: Osteonecrosis of the jaw (ONJ) in patients with metastatic breast cancer treated with denosumab in a randomized phase III trial comparing 4 vs. 12 weekly administration (REDUSE, SAKK 96/12)
Clinical Cancer Research·2025
Final Overall Survival Analysis of the Phase II SAKK 21/12 Trial of Transdermal CR1447 in Patients With Metastatic Breast Cancer
Clinical Breast Cancer·2025· 1 cited
Open-label nonrandomized phase IB study to characterize the safety and recommended dose of tinostamustine in combination with nivolumab in patients with advanced melanoma (ENIgMA)
Melanoma Research·2025
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study
European Journal of Cancer·2025· 2 cited
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland
Swiss Medical Weekly·2025· 1 citedOpen Access
Final Overall Survival (Os) Analysis of the Phase Ii Sakk 21/12 Trial of Transdermal Cr1447 in Patients with Metastatic Breast Cancer
SSRN Electronic Journal·2025Open Access
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
PLoS ONE·2024· 1 citedOpen Access
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)–SAKK 41/16
Clinical Colorectal Cancer·2024Open Access
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study
Cancer·2024· 3 citedOpen Access
Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison
Supportive Care in Cancer·2024· 4 citedOpen Access
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
Bone Reports·2024· 2 citedOpen Access
Abstract PS15-08: Final Overall Survival (OS) analysis of the SAKK 21/12 trial. CR1447 in HR+/HER2- metastatic breast cancer and androgen receptor positive triple negative breast cancer
Cancer Research·2024
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer
PLoS ONE·2024· 1 citedOpen Access
Un impact important sur la pratique des médecins
Bulletin des Médecins Suisses·2024Open Access
Praxisrelevante Auswirkungen für Ärztinnen und Ärzte
Schweizerische Ärztezeitung·2024Open Access
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma
Journal of Immunotherapy·2024· 4 cited
page 1 of 20Next →

Frequent Co-authors

Thomas Ruhstaller(7), Daniel Betticher(6), Viviane Hess(6), Saroj Vadhan‐Raj(5), Miklos Pless(5), Luís Costa(4), Roger Dansey(4), Reinhard Dummer(4), Beat Thürlimann(4), A. Roth(4), Charles S. Cleeland(4), Alison Stopeck(4), Lesley Fallowfield(4), Donald L. Patrick(4), Yi Qian(4), Ada Braun(4), Dieter Koeberle(4), Peter Brauchli(4), Sandro Anchisi(4), Walter Mingrone(4)